Literature DB >> 21427443

Clinical and electroencephalographic effects of folinic acid treatment in Rett syndrome patients.

Eveline E O Hagebeuk1, Johannes H T M Koelman, Marinus Duran, Nico G Abeling, Arno Vyth, Bwee-Tien Poll-The.   

Abstract

Rett syndrome is characterized by the development of stereotypic hand movements and seizures, which are often difficult to treat. Previous studies have shown conflicting results during add-on folinic acid. Here, the authors reevaluate the response to folinic acid in terms of epilepsy control and electroencephalography features. They performed a randomized, placebo-controlled, double-blind crossover trial, with a follow-up of more than 2 years. Twelve girls with Rett syndrome participated, comparable in clinical stage and disease severity. The Rett syndrome patients were given either folinic acid or placebo, for 1 year each. Only 3 girls benefited to some extent: 2 had a reduction and/or decrease in seizures, and all 3 showed some decreased epileptiform activity on electroencephalography during the addition of folinic acid. Despite this, antiepileptic drugs were adjusted. Because the effect of added folinic acid was limited and did not prevent antiepileptic drug increase, the authors do not recommend adding on folinic acid in Rett syndrome girls with epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21427443     DOI: 10.1177/0883073810390037

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  11 in total

Review 1.  Rett syndrome and MeCP2.

Authors:  Vichithra R B Liyanage; Mojgan Rastegar
Journal:  Neuromolecular Med       Date:  2014-03-11       Impact factor: 3.843

2.  S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid in Rett syndrome and the effect of folinic acid supplementation.

Authors:  Eveline E O Hagebeuk; Marinus Duran; Nico G G M Abeling; Arno Vyth; Bwee Tien Poll-The
Journal:  J Inherit Metab Dis       Date:  2013-02-08       Impact factor: 4.982

Review 3.  S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life.

Authors:  Jin Gao; Catherine M Cahill; Xudong Huang; Joshua L Roffman; Stefania Lamon-Fava; Maurizio Fava; David Mischoulon; Jack T Rogers
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

4.  IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients.

Authors:  Giorgio Pini; Maria Flora Scusa; Laura Congiu; Alberto Benincasa; Paolina Morescalchi; Ilaria Bottiglioni; Pietro Di Marco; Paolo Borelli; Ubaldo Bonuccelli; Andrea Della-Chiesa; Adriele Prina-Mello; Daniela Tropea
Journal:  Autism Res Treat       Date:  2012-06-13

5.  Adeno-associated virus-mediated rescue of the cognitive defects in a mouse model for Angelman syndrome.

Authors:  Jennifer L Daily; Kevin Nash; Umesh Jinwal; Todd Golde; Justin Rogers; Melinda M Peters; Rebecca D Burdine; Chad Dickey; Jessica L Banko; Edwin J Weeber
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

Review 6.  Neurobiologically-based treatments in Rett syndrome: opportunities and challenges.

Authors:  Walter E Kaufmann; Jennifer L Stallworth; David B Everman; Steven A Skinner
Journal:  Expert Opin Orphan Drugs       Date:  2016-09-10       Impact factor: 0.694

Review 7.  Key issues in Rett syndrome: emotional, behavioural and autonomic dysregulation (EBAD) - a target for clinical trials.

Authors:  Jatinder Singh; Paramala Santosh
Journal:  Orphanet J Rare Dis       Date:  2018-07-31       Impact factor: 4.123

Review 8.  Rett Syndrome: Crossing the Threshold to Clinical Translation.

Authors:  David M Katz; Adrian Bird; Monica Coenraads; Steven J Gray; Debashish U Menon; Benjamin D Philpot; Daniel C Tarquinio
Journal:  Trends Neurosci       Date:  2016-02       Impact factor: 13.837

Review 9.  Reviewing Evidence for the Relationship of EEG Abnormalities and RTT Phenotype Paralleled by Insights from Animal Studies.

Authors:  Kirill Smirnov; Tatiana Stroganova; Sophie Molholm; Olga Sysoeva
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

Review 10.  Pharmacological interventions for epilepsy in people with intellectual disabilities.

Authors:  Cerian F Jackson; Selina M Makin; Anthony G Marson; Michael Kerr
Journal:  Cochrane Database Syst Rev       Date:  2015-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.